{"name":"ProGen. Co., Ltd.","slug":"progen-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNU05OOHZzVWlfRlN0NVBra25GdGlBVEw3Nmp4d19VMklJSXZRUWozNkNtRy01WWtvX2NnLU1YSGpOa193TEF3UXdnMzBtek83UVVYc3RyX2wwZHBuWGdMdGNwbllLX2JnTS05UVhwek5iSFlfTlVFaE1RdUsxUUlnN2xKaGF2ZldkZFZCdFc0bWs0cjd5ZFAyOVJCTm9wc2hhTzlZR0NsdFJSNHdEcnRfeG1MWEEyYmNpeXRFR1ZRZGpkc0lycUJQczFsWHJqcmdWaF9wVi1BYUxDcXpXVzFSZ3EyNUJ3eHRpNXBEUXVpc3lYNFRjck1UX2ZJNGxaRDJLQlpVVF9Ecm5oYkJ5d0FPVG9lMWl3SkE0d3c?oc=5","date":"2026-01-08","type":"trial","source":"globenewswire.com","summary":"Rani Therapeutics Initiates Phase 1 Study of RT-114 - globenewswire.com","headline":"Rani Therapeutics Initiates Phase 1 Study of RT-114","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBkMUlWRy04S0ZqdldSdE1RVU1ObnVmaFl2bllqRXQ2NFVRWXZ0alF3Mm5ULW9Cc29DcmhLdFdvQzhkbHNoNHl5aFJTNzVBalRJcWpCb01SbkttNDV1VTlyVXhZWVNRQUdl?oc=5","date":"2025-07-09","type":"regulatory","source":"MarketBeat","summary":"Rani Therapeutics (RANI) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $RANI - MarketBeat","headline":"Rani Therapeutics (RANI) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $RANI","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jMWY4aW5GTnlGSHgxWVRYbkhoRk51a2xBd2VvZTIyX2xLM0xUTTVUMzNnLTM4NnR4cVp3MkMtQTNxc0lCUHU1SzJreFpQVTA5QXlB?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"Rani Therapeutics Holdings Stock Price, News & Analysis - Stock Titan","headline":"Rani Therapeutics Holdings Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE83amxNdjNjUHZscGdvU1hYOTRuZFA1WTBsdnlfYWRGeUw3Rk5LVWlKUmlURjRiLWVheFlmOG5lSm1ZMkIzQWZmam0xZ19DYlJTSC1n?oc=5","date":"2025-04-21","type":"pipeline","source":"Wowtale","summary":"PROGEN Raises USD 15.5 million to Develop Biopharmaceutical Drug for Obesity-Diabetes - Wowtale","headline":"PROGEN Raises USD 15.5 million to Develop Biopharmaceutical Drug for Obesity-Diabetes","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-26","type":"trial","source":"globenewswire.com","summary":"Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-1","headline":"Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBYOXZmWVM0MzdTNnZYN3NSbjhuenRaSV9IclVxZTNlWUJDb2EzRDVveXk4R05OODZxbm5RNkFmQjlDVHdEMzkzQlBBR2JHWjlydURHUDhqQmhJZWEyVUkza1VlMW9Zc2pUUV9zVE00RQ?oc=5","date":"2025-02-13","type":"pipeline","source":"medwatch.com","summary":"Advised by former Novo Nordisk boss: Biotech company turns weight-loss drug into robotic tablet - medwatch.com","headline":"Advised by former Novo Nordisk boss: Biotech company turns weight-loss drug into robotic tablet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9aSWtib2tXVFBtR0Z4ZTBPdXlOblZPdDhzZ2Fsa1JWZF8wR3ctQVZFM2hOTE9nbXBQdm5pWXJoRTczVmh6ejRpbmZtNGNlRGJjdDVXbkJMLUxqRVlKZll3eGZ1dlNmUElzckVuZXJwUGlKNHF0TVNxVUZRbw?oc=5","date":"2024-06-28","type":"deal","source":"Yahoo Finance","summary":"RANI: GLP-2 Deal Announced - Yahoo Finance","headline":"RANI: GLP-2 Deal Announced","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQaXJETlBqUWszdEhMMEhSeThHNnRsVVVCOS1jS1hlam1HdW9oQkVhcXptQVhsQkdVcGlOTGxoTjBvS0NPZ3kyVDdxamg4QlRjeVFkczF3WXNWY2dxUFhoRHV3Ti1ReGRwVmRCSHR4RlNhaE5FV3IwdU1OVjBZTEFmY0VmZ2lMMGF4YjgwelZjVEM0REJIV1VReWt3b3RpUkpWdTVHMWg5VHNTcXpSQTZQU2o2d2pHLTA?oc=5","date":"2024-06-24","type":"deal","source":"Contract Pharma","summary":"Rani, ProGen Partner to Co-Develop & Commercialize Oral Obesity Treatment - Contract Pharma","headline":"Rani, ProGen Partner to Co-Develop & Commercialize Oral Obesity Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQT2JMcHd5MFpLWVRQczFadWZUQ3dwSzljWW55YXNXcHhnVUNFeW1RLUZ1MEhvWEFSM3hKR2pkTG4tang2WDlEUWtpZnY4T1JMN2c1NmlzdmpXYzVFMldPWWpyUzh6MTU3LWRzQnFRYndHdExHRjRKV2NXMktxSVF2end1Q3Q4V1RxM1ROVm1obkg5UkxmYjR4VmljeTVkS0k?oc=5","date":"2024-05-08","type":"pipeline","source":"BioWorld News","summary":"Bio Korea 2024: What’s next after GLP-1 in obesity, diabetes? - BioWorld News","headline":"Bio Korea 2024: What’s next after GLP-1 in obesity, diabetes?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPS2VHeXpxRU9EblVuNHBFdzZyZHZkY1Q4TkRyUndidDNhV24zQVdqbVd0SVRzT0FNdFc5cHF5RUY1TC1tVmJlZ1lBb2N1TDVKNnZVNWd0dGN5bmdoajdHRVdmYkFmMWhjV0hVeDd0MGZ5OTJ0RHhaTjRTV1ZxaEluSkgtRHJhVlFVMGpFbnpOM0F5VG9tazV4Y2h3NEZ4RmNiTkR2cGcxNndPN0NUN0tOLWk5dUdtNk9qeUtiWWdmbDF2WW8zS3NYZ3hzOWVlZ3o1X3JGRjNPbW5aMHh4bDlSNWNoR2U0Q3FaTFlyN052RWFQaGw4ZU5KTGZQVUEzNkhjWEVsQ2l0TQ?oc=5","date":"2022-10-24","type":"pipeline","source":"Business Wire","summary":"Triumvira Immunologics Appoints Life Sciences Industry Leader Robert Williamson as President and Chief Business Officer - Business Wire","headline":"Triumvira Immunologics Appoints Life Sciences Industry Leader Robert Williamson as President and Chief Business Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}